☰

Meredith A. Collins, Ph.D. - Publications

Affiliations: 
2014 Cellular and Molecular Biology University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Cell Biology, Oncology
Tree Info Grants Similar researchers PubMed Report error

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Takano S, Reichert M, Bakir B, Das KK, Nishida T, Miyazaki M, Heeg S, Collins MA, Marchand B, Hicks PD, Maitra A, Rustgi AK. Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization. Genes & Development. 30: 233-47. PMID 26773005 DOI: 10.1101/Gad.263327.115  0.369
2016 Takano S, Reichert M, Bakir B, Das KK, Nishida T, Miyazaki M, Heeg S, Collins MA, Marchand B, Hicks PD, Maitra A, Rustgi AK. Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization Genes and Development. 30: 233-247. DOI: 10.1101/gad.263327.115  0.447
2015 Abravanel DL, Belka GK, Pan TC, Pant DK, Collins MA, Sterner CJ, Chodosh LA. Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy. The Journal of Clinical Investigation. 125: 2484-96. PMID 25961456 DOI: 10.1172/Jci74883  0.385
2015 Bednar F, Schofield HK, Collins MA, Yan W, Zhang Y, Shyam N, Eberle JA, Almada LL, Olive KP, Bardeesy N, Fernandez-Zapico ME, Nakada D, Simeone DM, Morrison SJ, Pasca di Magliano M. Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism. Carcinogenesis. PMID 25939753 DOI: 10.1093/Carcin/Bgv058  0.549
2015 Jiang W, Zhang Y, Kane KT, Collins MA, Simeone DM, di Magliano MP, Nguyen KT. CD44 regulates pancreatic cancer invasion through MT1-MMP. Molecular Cancer Research : McR. 13: 9-15. PMID 25566991 DOI: 10.1158/1541-7786.Mcr-14-0076  0.685
2015 Zhang Y, Yan W, Mathew E, Bednar F, Wan S, Collins MA, Evans RA, Welling TH, Vonderheide RH, Magliano MPd. Abstract A48: CD4+ T lymphocyte ablation prevents pancreatic carcinogenesis in mice Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-A48  0.453
2015 Schofield H, Bednar F, Collins M, Yan W, Zhang Y, Shyam N, Eberle J, Olive K, Bardeesy N, Nakada D, Simeone D, Morrison S, Magliano MPd. Abstract LB-061: Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-061  0.502
2014 Mathew E, Collins MA, Fernandez-Barrena MG, Holtz AM, Yan W, Hogan JO, Tata Z, Allen BL, Fernandez-Zapico ME, di Magliano MP. The transcription factor GLI1 modulates the inflammatory response during pancreatic tissue remodeling. The Journal of Biological Chemistry. 289: 27727-43. PMID 25104358 DOI: 10.1074/Jbc.M114.556563  0.686
2014 Zhang Y, Yan W, Mathew E, Bednar F, Wan S, Collins MA, Evans RA, Welling TH, Vonderheide RH, di Magliano MP. CD4+ T lymphocyte ablation prevents pancreatic carcinogenesis in mice. Cancer Immunology Research. 2: 423-35. PMID 24795355 DOI: 10.1158/2326-6066.Cir-14-0016-T  0.668
2014 Collins MA, Yan W, Sebolt-Leopold JS, Pasca di Magliano M. MAPK signaling is required for dedifferentiation of acinar cells and development of pancreatic intraepithelial neoplasia in mice. Gastroenterology. 146: 822-834.e7. PMID 24315826 DOI: 10.1053/J.Gastro.2013.11.052  0.44
2014 Zhang Y, Yan W, Bednar F, Wan S, Collins MA, Evans RA, Mathew E, Welling TH, Vonderheide RH, Magliano MPd. Abstract IA12: Oncogenic KRAS and the inflammatory microenvironment in pancreatic cancer Molecular Cancer Research. 12. DOI: 10.1158/1557-3125.Rasonc14-Ia12  0.577
2014 Zhang Y, Yan W, Mathew E, Bednar F, Wan S, Collins MA, Evans RA, Welling TH, Vonderheide RH, Magliano MPd. Abstract B23: CD4+ T lymphocytes promote pancreatic cancer progression by suppressing anti-tumor immune responses Molecular Cancer Research. 12. DOI: 10.1158/1557-3125.Rasonc14-B23  0.518
2013 Collins MA, Pasca di Magliano M. Kras as a key oncogene and therapeutic target in pancreatic cancer. Frontiers in Physiology. 4: 407. PMID 24478710 DOI: 10.3389/Fphys.2013.00407  0.526
2013 Zhang Y, Yan W, Collins MA, Bednar F, Rakshit S, Zetter BR, Stanger BZ, Chung I, Rhim AD, di Magliano MP. Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance. Cancer Research. 73: 6359-74. PMID 24097820 DOI: 10.1158/0008-5472.Can-13-1558-T  0.674
2013 Bednar F, Collins MA, Yan W, Zhang Y, Nakada D, Simeone DM, Morrison SJ, Pasca di Magliano M. Bmi1 is required for murine pancreatic cancer initiation Journal of the American College of Surgeons. 217: S133. DOI: 10.1016/J.Jamcollsurg.2013.07.309  0.47
2012 Collins MA, Brisset JC, Zhang Y, Bednar F, Pierre J, Heist KA, Galbán CJ, Galbán S, di Magliano MP. Metastatic pancreatic cancer is dependent on oncogenic Kras in mice. Plos One. 7: e49707. PMID 23226501 DOI: 10.1371/Journal.Pone.0049707  0.697
2012 Collins MA, Bednar F, Zhang Y, Brisset JC, Galbán S, Galbán CJ, Rakshit S, Flannagan KS, Adsay NV, Pasca di Magliano M. Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. The Journal of Clinical Investigation. 122: 639-53. PMID 22232209 DOI: 10.1172/Jci59227  0.596
2012 Collins MA, Zhang Y, Rakshit S, Sebolt-Leopold JS, Magliano MPd. Abstract B66: MAPK signaling mediates Kras-driven PanIN formation and maintenance. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-B66  0.508
2012 Zhang Y, Bednar F, Yan W, Collins MA, Rakshit S, Magliano MPD. Abstract A104: IL6 signaling is required for pancreatitis-induced pancreatic intra-epithelial neoplasia progression and maintenance in mice. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-A104  0.469
Show low-probability matches.